People: Insulet Corp (PODD.O)
Ms. Shacey Petrovic has been appointed President, Chief Executive Officer, Director effective January 1, 2019. Ms. Petrovic served as our Executive Vice President and President, Diabetes Products, and from February 2015 to February 2016, she served as our Chief Commercial Officer. From 2013 to 2015, Ms. Petrovic served as President and Chief Executive Officer of Clinical Innovations, LLC, a developer and manufacturer of medical devices and diagnostics for women’s health. From 2000 to 2013, Ms. Petrovic served in a number of key roles at Hologic, Inc. and Cytyc Corporation, which merged with Hologic in October 2007, including Vice President and General Manager of Hologic’s GYN Surgical Products division, as well as various sales and marketing leadership roles in the U.S. and Europe. Prior to joining Cytyc Corporation, Ms. Petrovic served as a Pharmaceutical Sales Specialist at AstraZeneca. Ms. Petrovic earned her Bachelor of Science in Biology from the University of Wisconsin.
|Total Annual Compensation, USD||1,397,310|
|Restricted Stock Awards, USD||1,625,000|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||633,100|
|Fiscal Year Total, USD||3,655,410|